Incidence
Five-year rate for joint surgery in PsA twice as high as general population
Ipragliflozin demonstrates efficacy among older Japanese adults with type 2 diabetes
Older Japanese adults with type 2 diabetes prescribed to the SGLT2 inhibitor ipragliflozin experienced a decline in HbA1c and body weight over 12 months that was similar to adults younger than 65 years, although researchers observed more serious adverse drug reactions among the older population, according to findings published in Current Medical Research and Opinion.
Top stories in hematology/oncology: Allergan recalls breast implants linked to lymphoma, FDA grants breakthrough therapy designation to hepatocellular carcinoma drug
The top stories in hematology/oncology last week both resulted from FDA actions: Allergan’s agreeing to the agency’s request to recall specific models of its breast implants that may be related to a rare type of lymphoma and the agency granting breakthrough therapy designation to the Keytruda-Lenvima combination for hepatocellular carcinoma.
Collaboration between cardiologists, oncologists may improve CV outcomes during, after cancer treatment
SAN ANTONIO — There continues to be an unmet need regarding CVD prevention in patients who are currently receiving cancer treatment or are cancer survivors, although partnership with cardiology and oncology may help improve outcomes, according to a presentation at the American Society for Preventive Cardiology Congress on CVD Prevention.
Colorectal cancer incidence among younger US adults continues to rise
Vena cava filters after major trauma fail to reduce incidence of pulmonary embolism, death
CAROLINA: Active-comparator study ‘vindicates’ glimepiride for CV safety
SAN FRANCISCO — A head-to-head comparison of the sulfonylurea glimepiride against the DPP-IV inhibitor linagliptin in a cohort of more than 6,000 adults with type 2 diabetes demonstrated no between-group differences for incidence of nonfatal myocardial infarction, nonfatal stroke and cardiovascular death during a median of 6 years, according to data from the CAROLINA trial presented at the American Diabetes Association Scientific Sessions.
Venous thromboembolism guidelines aim to clarify proper care in areas with ‘a lot of uncertainty’
College students at three times the risk for MenB
The overall incidence of meningococcal disease is low among college students in the United States, but they were over three times more likely to develop meningococcal B disease, or MenB, compared with those who did not attend college, according to research published in Pediatrics. The increased risk for disease among this population highlights the importance of vaccination, researchers said.